The Moving Average Convergence Divergence (MACD) for PRGO turned positive on October 12, 2026. Looking at past instances where PRGO's MACD turned positive, the stock continued to rise in 30 of 41 cases over the following month. The odds of a continued upward trend are 73%.
The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on PRGO as a result. In 60 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 69%.
Following a +4.26% 3-day Advance, the price is estimated to grow further. Considering data from situations where PRGO advanced for three days, in 179 of 281 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.
The Aroon Indicator entered an Uptrend today. In 120 of 204 cases where PRGO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 59%.
The 10-day RSI Indicator for PRGO moved out of overbought territory on October 19, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 26 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 84%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRGO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.
PRGO broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 7 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.892) is normal, around the industry mean (10.819). P/E Ratio (-1.292) is within average values for comparable stocks, (-7.131). Projected Growth (PEG Ratio) (1.142) is also within normal values, averaging (2.152). Dividend Yield (0.072) settles around the average of (0.038) among similar stocks. P/S Ratio (0.454) is also within normal values, averaging (178.797).
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. PRGO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 89 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRGO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
The 10-day RSI Oscillator for ZYBT moved out of overbought territory on October 12, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 10 instances where the indicator moved out of the overbought zone. In 10 of the 10 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.
ZYBT moved below its 50-day moving average on October 13, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ZYBT crossed bearishly below the 50-day moving average on September 23, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 5 of 5 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZYBT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
ZYBT broke above its upper Bollinger Band on October 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ZYBT entered a downward trend on October 08, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Momentum Indicator moved above the 0 level on October 09, 2026. You may want to consider a long position or call options on ZYBT as a result. In 30 of 35 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 86%.
The Moving Average Convergence Divergence (MACD) for ZYBT just turned positive on October 09, 2026. Looking at past instances where ZYBT's MACD turned positive, the stock continued to rise in 10 of 13 cases over the following month. The odds of a continued upward trend are 77%.
Following a +6.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where ZYBT advanced for three days, in 62 of 77 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. ZYBT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 42 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.656) is normal, around the industry mean (10.819). P/E Ratio (0.000) is within average values for comparable stocks, (-7.131). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.038) among similar stocks. P/S Ratio (3.795) is also within normal values, averaging (178.797).
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZYBT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
PRGO | ||
|---|---|---|
OUTLOOK RATING 1..100 | 35 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 7 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 98 | |
PRICE GROWTH RATING 1..100 | 36 | |
P/E GROWTH RATING 1..100 | 89 | |
SEASONALITY SCORE 1..100 | 23 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| PRGO | ZYBT | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 84% | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 67% | 1 day ago 79% |
| Momentum ODDS (%) | 1 day ago 69% | 1 day ago 86% |
| MACD ODDS (%) | 1 day ago 73% | 1 day ago 77% |
| TrendWeek ODDS (%) | 1 day ago 64% | 1 day ago 83% |
| TrendMonth ODDS (%) | 1 day ago 62% | 1 day ago 82% |
| Advances ODDS (%) | 6 days ago 64% | 1 day ago 81% |
| Declines ODDS (%) | 21 days ago 69% | 6 days ago 90% |
| BollingerBands ODDS (%) | 1 day ago 73% | 1 day ago 90% |
| Aroon ODDS (%) | 1 day ago 59% | 1 day ago 90% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
PRGO’s FA Score shows that 1 FA rating(s) are green while ZYBT’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
PRGO’s TA Score shows that 4 TA indicator(s) are bullish while ZYBT’s TA Score has 4 bullish TA indicator(s).
PRGO (@Pharmaceuticals: Generic) experienced а +5.20% price change this week, while ZYBT (@Pharmaceuticals: Generic) price change was +0.68% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.61%. For the same industry, the average monthly price growth was -6.52%, and the average quarterly price growth was +9.62%.
PRGO is expected to report earnings on Nov 04, 2026.
A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CRWU | 16.61 | 0.52 | +3.23% |
| T-REX 2X Long CRWV Daily Target ETF | |||
| ODDZ | 21.08 | 0.42 | +2.04% |
| Corgi Sports Betting & Gambling ETF (ODDZ) | |||
| GLIN | 44.90 | 0.45 | +1.02% |
| VanEck India Growth Leaders ETF (GLIN) | |||
| LRGG | 30.65 | N/A | +0.01% |
| Nomura Focused Large Growth ETF (LRGG) | |||
| SNXX | 10.02 | -0.09 | -0.89% |
| Tradr 2X Long SNDK Daily ETF (SNXX) | |||
A.I.dvisor indicates that over the last year, PRGO has been loosely correlated with SUPN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PRGO jumps, then SUPN could also see price increases.
| Ticker / NAME | Correlation To PRGO | 1D Price Change % | ||
|---|---|---|---|---|
| PRGO | 100% | +0.50% | ||
| SUPN - PRGO | 49% Loosely correlated | +3.49% | ||
| ELAN - PRGO | 37% Loosely correlated | -3.36% | ||
| EVO - PRGO | 35% Loosely correlated | +4.23% | ||
| PBH - PRGO | 35% Loosely correlated | -0.70% | ||
| ALVO - PRGO | 34% Loosely correlated | +1.79% | ||
More | ||||
A.I.dvisor tells us that ZYBT and PRGO have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZYBT and PRGO's prices will move in lockstep.
| Ticker / NAME | Correlation To ZYBT | 1D Price Change % | ||
|---|---|---|---|---|
| ZYBT | 100% | +2.76% | ||
| PRGO - ZYBT | 27% Poorly correlated | +0.50% | ||
| AYTU - ZYBT | 27% Poorly correlated | +2.55% | ||
| UTHR - ZYBT | 23% Poorly correlated | +1.98% | ||
| NBIX - ZYBT | 20% Poorly correlated | +3.66% | ||
| TKNO - ZYBT | 16% Poorly correlated | +8.68% | ||
More | ||||